FINOTTI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.840
AS - Asia 1.198
EU - Europa 896
SA - Sud America 247
AF - Africa 227
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 13
Totale 5.447
Nazione #
US - Stati Uniti d'America 2.702
SG - Singapore 464
CN - Cina 278
DE - Germania 274
BR - Brasile 164
HK - Hong Kong 122
FI - Finlandia 90
VN - Vietnam 78
UA - Ucraina 72
SE - Svezia 54
IT - Italia 51
GB - Regno Unito 49
FR - Francia 30
PL - Polonia 28
RU - Federazione Russa 25
NL - Olanda 22
PK - Pakistan 17
BE - Belgio 15
TR - Turchia 15
PS - Palestinian Territory 14
AR - Argentina 13
EC - Ecuador 13
GM - Gambi 11
JM - Giamaica 11
PR - Porto Rico 11
UY - Uruguay 11
BB - Barbados 10
HU - Ungheria 10
IN - India 10
LA - Repubblica Popolare Democratica del Laos 10
RS - Serbia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
ES - Italia 9
IE - Irlanda 9
IR - Iran 9
KZ - Kazakistan 9
MA - Marocco 9
MK - Macedonia 9
MX - Messico 9
NC - Nuova Caledonia 9
PT - Portogallo 9
SI - Slovenia 9
SN - Senegal 9
UZ - Uzbekistan 9
YE - Yemen 9
AF - Afghanistan, Repubblica islamica di 8
AL - Albania 8
BZ - Belize 8
CA - Canada 8
CU - Cuba 8
GR - Grecia 8
HR - Croazia 8
JO - Giordania 8
JP - Giappone 8
KE - Kenya 8
KH - Cambogia 8
PY - Paraguay 8
AM - Armenia 7
BD - Bangladesh 7
CI - Costa d'Avorio 7
CL - Cile 7
CV - Capo Verde 7
CW - ???statistics.table.value.countryCode.CW??? 7
EE - Estonia 7
GF - Guiana Francese 7
ID - Indonesia 7
KG - Kirghizistan 7
LT - Lituania 7
MY - Malesia 7
RO - Romania 7
TH - Thailandia 7
TN - Tunisia 7
VC - Saint Vincent e Grenadine 7
VE - Venezuela 7
YT - Mayotte 7
AD - Andorra 6
AO - Angola 6
BG - Bulgaria 6
CH - Svizzera 6
CO - Colombia 6
CR - Costa Rica 6
DZ - Algeria 6
GE - Georgia 6
GH - Ghana 6
HT - Haiti 6
IS - Islanda 6
MD - Moldavia 6
MG - Madagascar 6
ML - Mali 6
MW - Malawi 6
MZ - Mozambico 6
PE - Perù 6
PF - Polinesia Francese 6
PH - Filippine 6
RW - Ruanda 6
SD - Sudan 6
TJ - Tagikistan 6
TT - Trinidad e Tobago 6
Totale 5.189
Città #
Fairfield 274
Singapore 261
Jacksonville 238
Chandler 224
Woodbridge 217
Ashburn 204
Ann Arbor 198
Houston 187
Wilmington 132
Hong Kong 117
Cambridge 115
Seattle 99
Beijing 78
Princeton 77
Boardman 66
Santa Clara 50
Helsinki 42
Nanjing 40
Roxbury 32
San Diego 32
Des Moines 30
Medford 29
Nürnberg 25
Dong Ket 22
Padova 22
Los Angeles 21
Shenyang 20
Ho Chi Minh City 18
Bytom 17
Guangzhou 15
Hanoi 15
São Paulo 15
Hebei 13
Boston 12
Buffalo 11
Chicago 11
Kingston 10
New York 10
Bridgetown 9
Dakar 9
Norwalk 9
Noumea 9
Redwood City 9
Tashkent 9
Vientiane 9
Dublin 8
Montevideo 8
Phnom Penh 8
Amman 7
Athens 7
Belize City 7
Havana 7
Jinan 7
Kingstown 7
Skopje 7
Vienna 7
Yerevan 7
Abidjan 6
Abu Dhabi 6
Accra 6
Andorra la Vella 6
Bamako 6
Banjul 6
Bishkek 6
Dushanbe 6
Kampala 6
Kigali 6
Nairobi 6
Papeete 6
Reykjavik 6
San José 6
Tehran 6
Warsaw 6
Willemstad 6
Zagreb 6
Antakya 5
Antananarivo 5
Atlanta 5
Bangkok 5
Brasília 5
Brazzaville 5
Brooklyn 5
Brussels 5
Conakry 5
Dar es Salaam 5
Djibouti 5
Kinshasa 5
Kuala Lumpur 5
Libreville 5
Lilongwe 5
Ljubljana 5
Lusaka 5
Nanchang 5
Nassau 5
Panama City 5
Praia 5
Recife 5
Sanaa 5
Stockholm 5
Tianjin 5
Totale 3.382
Nome #
Identification and purification from the plasma of Type 1 diabetic subjects of a proteolytically active Grp94Evidence that Grp94 is entirely responsible for plasma proteolytic activity. 268
Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of Glucose-regulated protein94 (Grp94)-IgG complexes 200
Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells 199
Angiogenic transforming capacity of IgG purified from plasma of type 1 diabetic patients 193
Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions 179
Proteomic investigation on Grp94-IgG complexes circulating in plasma of type 1 diabetic subjects 177
Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationship with metabolic control. 176
Human IgGs induce synthesis and secretion of IgGs and neonatal Fc receptor in human umbilical vein endothelial cells 175
Long-term blood glucose control and diabetic retinopathy. 172
Characterization of immune complexes of idiotypic catalytic and anti-idiotypic inhibitory antibodies in plasma of type 1 diabetic subjects 172
Comment on: Antibodies to the endoplasmic reticulum-resident chaperones calnexin, Bip and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus 168
Stable complexes formed by Grp94 with human IgG promoting angiogenic differentiation of HUVECs by a cytokine-like mechanism. 163
Effects of Glucose-regulated protein94 (Grp94) on Ig secretion from human blood mononuclear cells 136
The role played by serine proteases in the development and worsening of vascular complications in Type 1 diabetes mellitus. 130
Albumin contamination of a purified human alpha1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor. 127
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 118
Inhibition of immunoglobulin secretion from peripheral blood mononuclear cells by glucose-regulated protein94 (Grp94) inallergic subjects 114
Biphasic pattern of heparin-induced oxidative degradation of trypsin in the presence of glucose. 112
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 112
Effects of Glucose-Regulated Protein94 (GRP94) and complexes of GRP94 with IgG on cells of the innate and adaptive immunity (SIF award for the best oral communication) 109
[Effects of digoxin on plasma renin activity in man. II]. 107
The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin 106
Complessi di Grp94 ed Immunoglobuline G umane 104
Separation by heparin-affinity chromatography of catalytically active and inactive forms of trypsin which retain the (Na-K)ATPase stimulating property. 103
A heat shock protein70 fusion protein with alpha(1)-antitrypsin in plasma of Type 1 diabetic subjects 102
Complexes of Grp94 with human Immunoglobulin G 100
Immune complexes of glucose-regulated protein94 (Grp94) with IgG, present in the plasma of type 1 diabetic subjects, show strong angiogenic-transforming capacity on HUVECs 100
Immune complexes of Glucose-regulated protein94 (Grp94) with IgG are present in the plasma of Type 1 diabetic subjects and show strong angiogenic-transforming capacity on HUVECs (oral communication) 98
Differential effects of heparin and glucose on structural conformation of human alpha1-antitrypsin: evidence for a heparin-induced cleaved form of the inhibitor. 96
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 96
Effects of intact and reduced reducing termini in heparin on structural and functional modifications of trypsin. 89
Differential Mechanism for structural and functional alterations of trypsin by heparin, evidence for a speific radical-generating mechanism at low heparin concentrations. 89
Heparin-induced structural and functional alterations of bovine trypsin. 89
Induction of angiogenesis by the heat shock protein Glucose-regulated protein94 (Grp94) mediated by a cytokine-like mechanism. 85
Effects of digoxin on plasma renin activity in hypertensive patients. 85
Heparin-induced structural modifications and oxidative cleavage of human serum albumin in the absence and presence of glucose. 84
Inhibition of dopamine beta-hydroxylase by captopril. 76
New insights into the molecular mechanism of heparin-protein interactions. Revisiting the role and function of heparin in the light of its oxidative property 74
Both a serine-like protease and a protease inhibitory activity are present in circulating immune complexes in type 1 diabetes mellitus. 72
Role of reducing terminals in unfractionated and low-molecular-mass heparins in causing free radical generation and loss of structure and activity of tripsin. 72
Heparin effects on glycated human serum albumin 70
Spin-trapping agent alpha-phenyl N-tert-butylnitrone binds to trypsin and enhances heparin-induced inhibition of amidolytic activity and structural degradation of the enzyme. 66
Sex and parental hypertension as predictors of worsened red blood cell membrane enzyme activities in type 1 insulin-dependent diabetic subjects. 62
IDENTIFICAZIONE DI UNA " GLUCOSE-REGULATED PROTEIN" 94 GRP94 MODIFICATA E USO DELLA STESSA E DI ANTICORPI ANTI-GRP94 NELLE COMPLICANZE VASCOLARI DEL DIABETE 61
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 61
Spin-trapping agent alpha-phenyl N-Tert-butylnitrone as inhibitor of trypsin and enhancer of the oxidative degradation of the enzyme by heparin 58
Purification of proteinase-like and Na+/K(+)-ATPase stimulating substance from plasma of insulin-dependent diabetics and its identification as alpha 1-antitrypsin 50
Totale 5.455
Categoria #
all - tutte 17.306
article - articoli 14.191
book - libri 210
conference - conferenze 0
curatela - curatele 0
other - altro 183
patent - brevetti 607
selected - selezionate 0
volume - volumi 0
Totale 32.497


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021308 0 0 0 0 38 38 9 42 58 22 60 41
2021/2022474 4 64 44 42 21 38 16 47 26 9 45 118
2022/2023454 90 63 12 42 68 76 0 31 41 1 25 5
2023/2024224 17 34 29 19 31 15 18 5 2 3 26 25
2024/2025851 0 37 35 51 138 25 36 63 84 20 150 212
2025/20261.492 128 278 387 528 171 0 0 0 0 0 0 0
Totale 5.455